Christopher Scudder
Feline Comorbidities: Hypersomatotropism-induced diabetes in cats
Scudder, Christopher; Church, David
Authors
David Church
Abstract
Practical relevance:
Diabetes mellitus is the second-most common feline endocrinopathy, affecting an estimated 1/200 cats. While the underlying causes vary, around 15-25% of cats with diabetes mellitus develop the condition secondarily to progressive growth hormone (GH)-induced insulin resistance. This typically results in a form of diabetes that is challenging to manage, whereby the response to insulin is very variable or high doses are required to achieve even minimal diabetic control.
Clinical challenges:
Although uncontrolled chronic excessive GH may result in phenotypic changes that raise suspicion for acromegaly, many cats with hypersomatotropism (HST) do not have these changes. In these situations, a clinician's index of suspicion may be increased by the presence of less dramatic changes such as marked polyphagia, stertor or uncontrolled diabetes mellitus. The current diagnostic test of choice is demonstration of a markedly increased serum insulin-like growth factor 1 (IGF1) concentration, but some affected cats will have only a marginal increase; additionally, chronic insulin administration in cats results in an increase in serum IGF1, making the diagnosis less clear cut and requiring additional confirmatory tests.
Evidence base:
Over the past two decades, HST has increasingly been recognised as an underlying cause of diabetes mellitus in cats. This review, which focuses on diagnosis and treatment, utilises data from observational studies, clinical trials and case series, as well as drawing on the experience of the authors in managing this condition.
Citation
Scudder, C., & Church, D. (2024). Feline Comorbidities: Hypersomatotropism-induced diabetes in cats. Journal of Feline Medicine and Surgery, 26(2), https://doi.org/10.1177/1098612x241226690
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 2, 2024 |
Online Publication Date | Feb 7, 2024 |
Publication Date | 2024-02 |
Deposit Date | Aug 23, 2024 |
Publicly Available Date | Aug 27, 2024 |
Journal | Journal of Feline Medicine and Surgery |
Print ISSN | 1098-612X |
Electronic ISSN | 1532-2750 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 26 |
Issue | 2 |
DOI | https://doi.org/10.1177/1098612x241226690 |
Publisher URL | https://journals.sagepub.com/doi/full/10.1177/1098612X241226690 |
Files
Feline Comorbidities: Hypersomatotropism-induced Diabetes In Cats
(3.1 Mb)
PDF
Licence
http://creativecommons.org/licenses/by-nc/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/
Version
VoR
You might also like
Feline hypersomatotropism and acromegaly tumorigenesis: a potential role for the AIP gene
(2017)
Journal Article
Call for coordinated antimicrobial approach at veterinary diagnostic laboratories
(-0001)
Journal Article
Suspected congenital hyperinsulinism in a Shiba Inu dog
(2020)
Journal Article
Regulation and Function of C-Type Natriuretic Peptide (CNP) in Gonadotrope-Derived Cell Lines
(-0001)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search